These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27543259)

  • 1. High intensity focused ultrasound with Focal-One
    Perez-Reggeti JI; Sanchez-Salas R; Sivaraman A; Linares Espinos E; de Gracia-Nieto AE; Barret E; Galiano M; Rozet F; Fregeville A; Renard-Penna R; Cathala N; Mombet A; Prapotnich D; Cathelineau X
    Actas Urol Esp; 2016 Dec; 40(10):608-614. PubMed ID: 27543259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes.
    Feijoo ER; Sivaraman A; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Prapotnich D; Cathala N; Mombet A; Cathelineau X
    Eur Urol; 2016 Feb; 69(2):214-20. PubMed ID: 26164416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer.
    Rosenhammer B; Niessen C; Rotzinger L; Reiss J; Schnabel MJ; Burger M; Bründl J
    Urol Int; 2019; 103(3):270-278. PubMed ID: 31466073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIFU focal therapy for prostate cancer using intraoperatory contrast enhanced ultrasound.
    Claros OR; Tourinho-Barbosa RR; Carneiro A; Collura-Merlier S; Macek P; Lanz C; Cathala N; Prapotnich D; Mombet A; Sanchez-Salas R; Cathelineau X
    Arch Esp Urol; 2019 Oct; 72(8):825-830. PubMed ID: 31579041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
    Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
    J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
    von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
    Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
    Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
    Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer.
    Guillaumier S; Peters M; Arya M; Afzal N; Charman S; Dudderidge T; Hosking-Jervis F; Hindley RG; Lewi H; McCartan N; Moore CM; Nigam R; Ogden C; Persad R; Shah K; van der Meulen J; Virdi J; Winkler M; Emberton M; Ahmed HU
    Eur Urol; 2018 Oct; 74(4):422-429. PubMed ID: 29960750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
    Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
    J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective clinical trial of HIFU hemiablation for clinically localized prostate cancer.
    van Velthoven R; Aoun F; Marcelis Q; Albisinni S; Zanaty M; Lemort M; Peltier A; Limani K
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):79-83. PubMed ID: 26597660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
    Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
    Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Exploratory Study of Dose Escalation
    Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
    J Endourol; 2020 Jun; 34(6):641-646. PubMed ID: 32253928
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-Whole-Gland High-Intensity Focused Ultrasound vs Whole-Gland High-Intensity Focused Ultrasound for Management of Localized Prostate Cancer: 1-Year Oncological and Functional Outcomes.
    Lei Y; Zanker P; Yildiz S; Hancke K; Seidl D; Koch O; Schwentner C; Mundhenk J
    J Endourol; 2019 Feb; 33(2):100-106. PubMed ID: 30526029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancer.
    Kanthabalan A; Peters M; Van Vulpen M; McCartan N; Hindley RG; Emara A; Moore CM; Arya M; Emberton M; Ahmed HU
    BJU Int; 2017 Aug; 120(2):246-256. PubMed ID: 28258616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer.
    Rompré-Brodeur A; Marcq G; Tholomier C; Fugaru I; Loutochin O; Anidjar M; Bladou F
    J Urol; 2021 Nov; 206(5):1177-1183. PubMed ID: 34251879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage Hemiablation High Intensity Focused Ultrasound for unilateral radio-recurrent prostate cancer.
    Aoun F; Albisinni S; Biaou I; Peltier A; Limani K; Roumeguère T; van Velthoven R
    Prog Urol; 2019 Oct; 29(12):627-633. PubMed ID: 31400963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation.
    Khandwala YS; Morisetty S; Ghanouni P; Fan RE; Soerensen SJC; Rusu M; Sonn GA
    Urol Oncol; 2022 Nov; 40(11):489.e9-489.e17. PubMed ID: 36058811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal High-intensity Focussed Ultrasound Partial Gland Ablation for the Treatment of Localised Prostate Cancer: A Report of Medium-term Outcomes From a Single-center in the United Kingdom.
    Johnston MJ; Emara A; Noureldin M; Bott S; Hindley RG
    Urology; 2019 Nov; 133():175-181. PubMed ID: 31449831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
    Pfeiffer D; Berger J; Gross AJ
    BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.